Great Point Partners sets up new hub in London

• Noah Rhodes, MD, and head of private equity, will lead the development of the new office
• GPP has hired two London-based executives, including David Slattery, senior VP, and Isaac Kang, associate
• The firm manages over $1.9bn of capital in its private funds and public life sciences equity strategy

Great Point Partners (GPP) has opened a new office in London in an aim to expand its ability to help health care companies reach transatlantic scale.

GPP’s London office is part of its strategy to integrate both its North American and European networks to support existing and future portfolio companies, according to a release.

“Our London office will enable us to strengthen our partnerships with entrepreneurs to build global health care businesses,” said Jeffrey Jay, MD, founder, and managing partner of GPP. “This expansion is a testament to our success in helping US -based companies expand into European markets and vice versa.”

Noah Rhodes, MD, and head of private equity, will lead the development of the new office both from the US and in London.

“We believe that having an on-the-ground presence in Europe will benefit both our existing and prospective partners in accelerating their growth and expanding internationally, and also conveys our commitment to the European market,” Rhodes said.

GPP has hired two London-based executives, including David Slattery, senior VP, and Isaac Kang, associate.

GPP has helped several healthcare companies reach transatlantic scale, including MaSTherCell, Softbox, CorEvitas, MLM Medical Labs, SteriPack, and Clinical Supplies Management, the release added.

GPP, based in Greenwich, Connecticut, is a health care investment firm. The firm invests in the US, Canada, and Western Europe. It manages over $1.9 billion (€1.73 billion) of capital in its private funds and public life sciences equity strategy.